NCT05768139: First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 880 planned
- Started
- 17 Apr 2023
- Primary completion
- Jul 2030
- Arms
- Dose Escalation (Advanced Solid Tumors), Dose Expansion
- Results
- None posted
- 14 Mar 2023: Trial registered
- 17 Apr 2023: Trial started